Literature DB >> 17992190

Tumor stress, cell death and the ensuing immune response.

E Ullrich1, M Bonmort, G Mignot, G Kroemer, L Zitvogel.   

Abstract

A cornucopia of physiological and pathological circumstances including anticancer chemotherapy and radiotherapy can induce cell death. However, the immunological consequences of tumor cell demise have remained largely elusive. The paradigm opposing 'apoptosis versus necrosis' as to their respective immunogenicity does not currently hold to predict long-term immunity. Moreover, the notion that tumor cells may be 'stressed' before death to be recognized by immune cells deserves to be underlined. 'Eat-me', 'danger' and 'killing' signals released by stressed tumor under the pressure of cytotoxic compounds may serve as links between the chemotherapy-elicited response of tumor cells and subsequent immune responses. This review will summarize the state-of-the-art of cancer immunity and describe how tumor cell death dictates the links between innate and acquired immunity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17992190     DOI: 10.1038/sj.cdd.4402266

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  29 in total

1.  Identification of genes associated with tumor development in CaSki cells in the cosmic space.

Authors:  Fengjie Guo; Yalin Li; Yan Liu; Jian Huang; Zhijie Zhang; Jiajia Wang; Yuehui Li; Jinyue Hu; Guancheng Li
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

Review 2.  What's the place of immunotherapy in malignant mesothelioma treatments?

Authors:  Marc Grégoire
Journal:  Cell Adh Migr       Date:  2010-01-30       Impact factor: 3.405

Review 3.  Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells.

Authors:  Thomas S Griffith; Thomas A Ferguson
Journal:  Immunity       Date:  2011-10-28       Impact factor: 31.745

Review 4.  The evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells.

Authors:  M Zanetti; J J Rodvold; N R Mahadevan
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

Review 5.  In-situ tumor vaccination: Bringing the fight to the tumor.

Authors:  Robert H Pierce; Jean S Campbell; Sara I Pai; Joshua D Brody; Holbrook E K Kohrt
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Fever-range whole body thermotherapy combined with oxaliplatin: a curative regimen in a pre-clinical breast cancer model.

Authors:  R Wanda Rowe; Frederick R Strebel; Jesse M Proett; Wanleng Deng; Diana Chan; Guangan He; Zahid Siddik; Joan M C Bull
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

7.  Upregulation of heat shock proteins and the promotion of damage-associated molecular pattern signals in a colorectal cancer model by modulated electrohyperthermia.

Authors:  Gabor Andocs; Nora Meggyeshazi; Lajos Balogh; Sandor Spisak; Mate Elod Maros; Peter Balla; Gergo Kiszner; Ivett Teleki; Csaba Kovago; Tibor Krenacs
Journal:  Cell Stress Chaperones       Date:  2014-06-29       Impact factor: 3.667

8.  Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myeloma.

Authors:  Xiaosong Wu; Yi Tao; Jun Hou; Xiuqin Meng; Jumei Shi
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

Review 9.  Therapeutic applications of TRAIL receptor agonists in cancer and beyond.

Authors:  Gustavo P Amarante-Mendes; Thomas S Griffith
Journal:  Pharmacol Ther       Date:  2015-09-05       Impact factor: 12.310

10.  Using optical spectroscopy to longitudinally monitor physiological changes within solid tumors.

Authors:  Karthik Vishwanath; Hong Yuan; William T Barry; Mark W Dewhirst; Nimmi Ramanujam
Journal:  Neoplasia       Date:  2009-09       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.